Literature DB >> 8921292

The competitive transport inhibitor L-trans-pyrrolidine-2, 4-dicarboxylate triggers excitotoxicity in rat cortical neuron-astrocyte co-cultures via glutamate release rather than uptake inhibition.

A Volterra1, P Bezzi, B L Rizzini, D Trotti, K Ullensvang, N C Danbolt, G Racagni.   

Abstract

We studied the early and late effects of L-trans-pyrrolidine-2,4-dicarboxylate (PDC), a competitive inhibitor of glutamate uptake with low affinity for glutamate receptors, in co-cultures of rat cortical neurons and glia expressing spontaneous excitatory amino acid (EAA) neurotransmission. At 100 or 200 microM, PDC induced different patterns of electrical changes: 100 microM prolonged tetrodotoxin-sensitive excitation triggered by synaptic glutamate release; 200 microM produced sustained, tetrodotoxin-insensitive and EAA-mediated neuronal depolarization, overwhelming synaptic activity. At 200 microM, but not at 100 microM, PDC caused rapid elevation of the glutamate concentration ([Glu]o) in the culture medium, resulting in NMDA receptor-mediated excitotoxic death of neurons 24 h later. The increase in [Glu]o was largely insensitive to tetrodotoxin, independent of extracellular Ca2+, and present also in astrocyte-pure cultures. By the use of glutamate transporters functionally reconstituted in liposomes, we showed directly that PDC activates carrier-mediated release of glutamate via heteroexchange. Glutamate release and delayed neurotoxicity in our cultures were suppressed if PDC was applied in a Na(+)-free medium containing Li+. However, replacement of Na+ with choline instead of Li+ did not result in an identical effect, suggesting that Li+ does not act simply as an external Na+ substitute. In conclusion, our data indicate that alteration of glutamate transport by PDC has excitotoxic consequences and that active release of glutamate rather than just uptake inhibition is responsible for the generation of neuronal injury.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8921292     DOI: 10.1111/j.1460-9568.1996.tb01345.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  27 in total

1.  Substrate turnover by transporters curtails synaptic glutamate transients.

Authors:  S Mennerick; W Shen; W Xu; A Benz; K Tanaka; K Shimamoto; K E Isenberg; J E Krause; C F Zorumski
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

2.  Activity-dependent recruitment of extrasynaptic NMDA receptor activation at an AMPA receptor-only synapse.

Authors:  Beverley A Clark; Stuart G Cull-Candy
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

3.  Glutamate-glutamine cycle and aging in striatum of the awake rat: effects of a glutamate transporter blocker.

Authors:  G Segovia; A Del Arco; L Prieto; F Mora
Journal:  Neurochem Res       Date:  2001-01       Impact factor: 3.996

4.  Conditional deletion of the glutamate transporter GLT-1 reveals that astrocytic GLT-1 protects against fatal epilepsy while neuronal GLT-1 contributes significantly to glutamate uptake into synaptosomes.

Authors:  Geraldine T Petr; Yan Sun; Natalie M Frederick; Yun Zhou; Sameer C Dhamne; Mustafa Q Hameed; Clive Miranda; Edward A Bedoya; Kathryn D Fischer; Wencke Armsen; Jianlin Wang; Niels C Danbolt; Alexander Rotenberg; Chiye J Aoki; Paul A Rosenberg
Journal:  J Neurosci       Date:  2015-04-01       Impact factor: 6.167

Review 5.  Mechanisms of glutamate release from astrocytes.

Authors:  Erik B Malarkey; Vladimir Parpura
Journal:  Neurochem Int       Date:  2007-06-26       Impact factor: 3.921

6.  Astrocytic control of synaptic NMDA receptors.

Authors:  C Justin Lee; Guido Mannaioni; Hongjie Yuan; Dong Ho Woo; Melissa B Gingrich; Stephen F Traynelis
Journal:  J Physiol       Date:  2007-04-05       Impact factor: 5.182

7.  Modulation of extracellular glutamate concentration in rat brain slices by cystine-glutamate exchange.

Authors:  O Warr; M Takahashi; D Attwell
Journal:  J Physiol       Date:  1999-02-01       Impact factor: 5.182

Review 8.  Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease.

Authors:  Kou Takahashi; Joshua B Foster; Chien-Liang Glenn Lin
Journal:  Cell Mol Life Sci       Date:  2015-06-02       Impact factor: 9.261

9.  Marked synergism between mutant SOD1 and glutamate transport inhibition in the induction of motor neuronal degeneration in spinal cord slice cultures.

Authors:  Hong Z Yin; John H Weiss
Journal:  Brain Res       Date:  2012-02-09       Impact factor: 3.252

10.  Acute decrease in net glutamate uptake during energy deprivation.

Authors:  D Jabaudon; M Scanziani; B H Gähwiler; U Gerber
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.